43 results on '"Xiao, Binyi"'
Search Results
2. The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study
3. Insight into the mechanism of nitrogen doping in MXenes with controllable surface chemistry
4. Engineering surface electronic of MXene to boost pseudocapacitive behavior
5. DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer
6. Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer
7. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas
8. KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.
9. Comparisons of screening strategies for identifying Lynch syndrome among patients with MLH1-deficient colorectal cancer
10. Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer
11. Nonoperative Management of dMMR/MSI-H Colorectal Cancer following Neoadjuvant Immunotherapy: A Narrative Review
12. Dickkopf-related protein 1, a new biomarker for local immune status and poor prognosis among patients with colorectal liver Oligometastases: a retrospective study
13. A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions.
14. Assessment of the Necessity of Gastrocolic Ligament Lymph Node Dissection and Related Risk Factors in Right Hemicolectomy for Colon Cancer: A Prospective Continuous Observational Study
15. Efficacy of Pd-1 Inhibitors for Colorectal Cancer and Polyps in Lynch Syndrome Patients
16. Development and Validation of Serum Nomogram for Colorectal Cancer Screening
17. Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study
18. DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer
19. B2M and JAK1/2–mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 Therapy
20. RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases
21. Inflammatory Conditions Promote Resistance to Immune Checkpoint Inhibitors in High Microsatellite Instability Colorectal Cancer
22. Corrigendum to “Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer” [Canc. Lett. 500 (2021) 119-131]
23. Additional file 2 of Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer
24. Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
25. Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer
26. Surgery Prolongs the Survival of Patients with Metastatic, Recurrent, or Unresectable Locally Advanced Gastrointestinal Stromal Tumors Response to Imatinib Mesylate Treatment: A Systematic Review and Meta-analysis
27. Prognostic value of tumor infiltrating lymphocytes combined with PD-L1 expression for patients with solitary colorectal cancer liver metastasis
28. Serum Gamma Glutamyl transferase is a predictor of recurrence after R0 hepatectomy for patients with colorectal cancer liver metastases
29. Immune Cell Infiltration in the Microenvironment of Liver Oligometastasis from Colorectal Cancer: Intratumoural CD8/CD3 Ratio Is a Valuable Prognostic Index for Patients Undergoing Liver Metastasectomy
30. An early report of a screening program for colorectal cancer in Guangzhou, China
31. Immune Cell Infiltration in Liver Oligometastasis Microenvironment from Colorectal Cancer: Intratumoral CD8/CD3 Ratio Represents a Valuable Prognostic Index for Patients Undergoing Liver Metastasectomy
32. Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection
33. TROP2 overexpression in colorectal liver oligometastases is associated with poor prognosis after liver resection
34. Liver surgery prolongs the survival of patients with gastrointestinal stromal tumor liver metastasis: a retrospective study from a single center
35. Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer
36. RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma
37. PACE: A phase III trial of CAPOX versus anti-PD-1 inhibitor as adjuvant therapy for patients with dMMR/MSI-H stage III colon cancer.
38. Safety and effectiveness of subtotal pelvic peritonectomy for patients with colorectal cancer with limited peritoneal metastasis in pelvic cavity.
39. Efficacy of PD-1 inhibitors for colorectal cancer and polyps in patients with Lynch syndrome.
40. Voltage-gated sodium channel Nav1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.
41. RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases.
42. Voltage-gated sodium channel Na v 1.5 promotes tumor progression and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.
43. [Surgical treatment and prognostic analysis for 57 patients with gastrointestinal lymphoma].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.